OR WAIT null SECS
April 09, 2018
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
National Institutes of Health researchers use genomics to show that squamous cell carcinomas differ from other cancers, which could advance treatments for head and neck and other cancers.
March 27, 2018
Gyros Protein Technologies’ new immunoassay technology includes expanded software to optimize time to results and sample capacity while simplifying workflows.
March 01, 2018
The author discusses the advantages of high-throughput screening of drug formulation excipients by a fully automated Tecan-robotic system.
February 28, 2018
PharmaMar has released the results of MI130004, a novel antibody drug conjucate created using a molecule of marine origin.
February 22, 2018
The research partnership will focus on advancing regenerative medicine using porcine bioproducts.
February 02, 2018
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
February 01, 2018
Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.
January 16, 2018
The acquisition strengthens Charles River Laboratories’ capabilities in the oncology and immunology therapeutic areas.
January 12, 2018
The acquisition, valued at EUR 520 million (US$631 million), would expand Takeda’s late-stage pipeline in gastroenterology and would extend an already existing collaboration between the two companies.